help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 25, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2089
A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/10/3803    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanhorebeek, I.
Right arrow Articles by Van den Berghe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanhorebeek, I.
Right arrow Articles by Van den Berghe, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE

Submitted on September 20, 2005
Accepted on July 19, 2006

Cortisol response to critical illness: effect of intensive insulin therapy

Ilse Vanhorebeek, Robin P. Peeters, Sarah Vander Perre, Ivo Jans, Pieter J. Wouters, Kristin Skogstrand, Troels K. Hansen, Roger Bouillon, and Greet Van den Berghe*

Department of Intensive Care Medicine, Catholic University of Leuven, Leuven, Belgium (I.V., S.V.P., P.J.W., G.V.d.B.), Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands (R.P.P.), Laboratory for Experimental Medicine and Endocrinology, Catholic University of Leuven, Leuven, Belgium (I.J., R.B.), Department of Clinical Biochemistry, Statens Serum Institut, Copenhagen, Denmark (K.S.), NANEA, Department of Epidemiology and Social Medicine, Aarhus University, Aarhus, Denmark (K.S.), and Immunoendocrine Research Unit, Medical Department M, Aarhus University Hospital, Aarhus, Denmark (T.K.H.)

* To whom correspondence should be addressed. E-mail: greta.vandenberghe{at}med.kuleuven.be.

Context: Both excessive and insufficient activation of the hypothalamic-pituitary-adrenal axis in response to critical illness are associated with increased mortality.

Objective: To study the effect of intensive insulin therapy, recently shown to reduce mortality and morbidity of critically ill patients, on the cortisol response to critical illness.

Design: Pre-planned subanalysis of a large randomized controlled study measuring serum total cortisol, cortisol-binding globulin (CBG) and albumin, and calculating free cortisol levels.

Setting: University hospital surgical intensive care unit.

Patients: 451 critically ill patients dependent on intensive care for more than 5 days and 45 control subjects matched for gender, age, height and weight.

Intervention: Strict blood glucose control to normoglycemia with insulin.

Results: Total and calculated free cortisol levels were equally elevated upon admission in both patient groups, and thereafter were lower in intensive insulin-treated patients. Lower cortisol levels statistically related to the outcome benefit of intensive insulin therapy. CBG levels and structure were affected by critical illness, but not by insulin therapy, neither were albumin levels. Administration of hydrocortisone in so-called "replacement dose" resulted in several fold higher total and free cortisol levels, indicating that re-evaluation of the doses used is warranted.

Conclusion: Lower serum cortisol levels in critically ill patients receiving intensive insulin therapy statistically related to improved outcome with this intervention. The lower cortisol levels were not related to altered cortisol-binding capacity.


Key words: Cortisol • critical illness • insulin




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
M. S. Cooper and P. M. Stewart
Adrenal Insufficiency in Critical Illness
J Intensive Care Med, November 1, 2007; 22(6): 348 - 362.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Christ-Crain, D. Stolz, S. Jutla, O. Couppis, C. Muller, R. Bingisser, P. Schuetz, M. Tamm, R. Edwards, B. Muller, et al.
Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Mebis, L. Langouche, T. J. Visser, and G. Van den Berghe
The Type II Iodothyronine Deiodinase Is Up-Regulated in Skeletal Muscle during Prolonged Critical Illness
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3330 - 3333.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Vanhorebeek, L. Langouche, and G. Van den Berghe
Tight Blood Glucose Control With Insulin in the ICU: Facts and Controversies
Chest, July 1, 2007; 132(1): 268 - 278.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society